CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 24,322	$ 21,915
General and administrative	8,004	8,507
Total operating expenses	32,326	30,422
Loss from operations	(32,326)	(30,422)
Other income:
Interest income	1,522	1,989
Total other income	1,522	1,989
Net loss	$ (30,804)	$ (28,433)
Net loss per share attributable to common stockholders, basic	$ (0.45)	$ (0.43)
Net loss per share attributable to common stockholders, diluted	$ (0.45)	$ (0.43)
Weighted-average common shares outstanding, basic	68,030,966	66,265,703
Weighted-average common shares outstanding, diluted	68,030,966	66,265,703
Other comprehensive income (loss):
Unrealized (loss) gain on available for sale marketable securities	$ (10)	$ 596
Total other comprehensive (loss) income	(10)	596
Comprehensive loss	$ (30,814)	$ (27,837)